2013年第三季度智利制药及保健市场研究报告——Chile Pharmaceuticals and Healthcare Report Q3 2013

纸介版价格:美元/篇 页数:127页上传日期:2013-07-12
电子版价格:1295美元/篇
纸介版+电子版价格:美元 附件下载:               
关键字: |Pharmaceuticals|Healthcare|

2013-7-10


Abstract

BMI View: The lack of vigilance in bioequivalence regulations in Chile has allowed for the proliferation of
low quality medicines in the market. These can risk patients' lives and negatively affect the local
pharmaceutical industry's global competitiveness. Despite the ongoing capacity issues reported by domestic
manufacturers, we believe generic drugmakers in Chile need to adopt necessary production processes to
guarantee their drug quality.
Headline Expenditure Projections
■ Pharmaceuticals: CLP1,603bn (US$3.3bn) in 2012 to CLP1,715bn (US$3.6bn) in 2013; +7.0% in local
currency terms and +8.9% in US dollar terms.
■ Healthcare: CLP9,825bn (US$20.2bn) in 2012 to CLP10,629bn (US$22.3bn) in 2013; +8.2% in local
currency terms and +10.2% in US dollar terms.

Table of Contents

BMI Industry View ... 7
SWOT  9
Political . 11
Economic ..... 13
Business Environment  14
Industry Forecast .. 15
Pharmaceutical Market Forecast .... 15
Table: Chile Pharmaceutical Sales, Historical Data and Forecasts 2009 - 2017  . 16
Healthcare Market Forecast .... 17
Table: Healthcare Expenditure Trends, Historical Data & Forecasts, 2012-2017 . . . 20
Table: Governmental Healthcare Trends, Historical Data & Forecasts, 2012-2017 . 20
Table: Private Healthcare Trends, Historical Data & Forecasts, 2012-2017   21
Prescription Market Forecast .. 22
Table: Chile Prescription Drug Market Indicators, Historical Data & Forecasts  . 23
Patented Drug Market Forecast ..... 24
Table: Chile Patented Drug Market Indicators, Historical Data & Forecasts, 2009-201725
Generic Drug Market Forecast  26
Table: Chile Generic Drug Market Indicators, Historical Data & Forecasts, 2009-201727
OTC Medicine Market Forecast ..... 28
Table: Chile Over-The-Counter (OTC) Medicine Market Indicators, Historical Data & Forecasts, 2009-2011  . 29
Pharmaceutical Trade Forecast ..... 30
Table: Chile Exports & Imports Indicators, 2009-2017 32
Other Healthcare Data ..... 33
Key Risks To BMI's Forecast Scenario ... 34
Macroeconomic Forecasts ..... 35
Macroeconomic Forecast .. 35
Table: Chile - Economic Activity      . . . 44
Industry Risk Reward Ratings  45
Americas Risk/Reward Ratings . 45
Industry Risk Reward Ratings .. 50
Rewards ..... 50
Risks .... 51
Market Overview ... 52
Industry Trends And Developments .. 54
Epidemiology .... 54
Healthcare Sector .... 56
Table: Isapres Beneficiaries, 1990-2009    . . . 57
Table: Beneficiaries by Isapre Type, 2009    . 58
Healthcare Sector Developments ... 63
Table: Physicians by Specialty, 2000-2009    . 66
Healthcare Insurance  66
Research And Development .... 69
Clinical Trials ... 71
Regulatory Development .. 73
Regulatory Regime ..... 73
Regulatory Regime ... 73
Regulatory Developments  74
Table: Latin American Regulations On Bioequivalence And GMP      81
Intellectual Property Issues .... 81
Trade Agreements .... 84
Pricing Regime .. 85
Public Procurement .. 86
Table: Pharmaceutical Price Build-up (%)    87
Reimbursement Regime ... 88
Competitive Landscape .... 90
Pharmaceutical Sector .... 90
Domestic Industry .... 90
Foreign Industry  91
Pharmaceutical Distribution .. 93
Pharmaceutical Retail Sector . 93
Table: Pharmacy Sales Value by Sector, 2007-2008 (US$mn)       . 97
Table: Pharmacy Sales Volume by Sector, 2007-2008 (Million Units)     97
Company Profile .... 98
Laboratorios Chile (LabChile) . 98
Corporación Farmacéutica Recalcine (CFR) .... 101
Laboratorios Andrómaco  105
Pfizer .. 108
Novartis ..... 110
Sanofi .. 112
GlaxoSmithKline ..... 114
Merck & Co  116
Other Company Developments ..... 117
Demographic Forecast ... 119
Table: Chile's Population By Age Group, 1990-2020 ('000)       . . 120
Table: Chile's Population By Age Group, 1990-2020 (% of total)      121
Table: Chile's Key Population Ratios, 1990-2020  122
Table: Chile's Rural And Urban Population, 1990-2020. . 122
Glossary ... 123
Methodology .. 125
Pharmaceutical Expenditure Forecast Model .. 125
Healthcare Expenditure Forecast Model ... 125
Notes On Methodology .. 126

定购方法
① 注册订购:
点击在线订购进行报告订购
我们的服务人员将在24小时内与您联系。

② 电话订购:
拔打电话
北京:400 0090050   010-82863481
24小时:13436696826
传真:010-82601570

上海:021-64871266
021-64872612
24小时:13524982235
传真:021-64872324

签订协议
可从网上下载报告订购表或由我们传真报告订购表或订购协议。
传真:010-82601570

付款方式
① 通过银行转帐的形式支付报告购买款项
② 我们收到款项后,24小时内快递报告或者发送报告邮件

③ 款项到帐后快递发票

银行电汇:
北京:
开户行:
上海浦东发展银行北京知春路支行
帐号:91170154740001300
户名:北京佐思信息咨询有限责任公司
外币汇款账户信息:
BENEFICIARY’S BANK (受益人银行名称):
SHANGHAI PUDONG DEVELOPMENT BANK, H.O. SHANGHAI, CHINA
SWIFT:
SPDBCNSH390
BENEFICIARY’S A/C NO. (受益人帐号):
911 701 547 4000 1300
BENEFICIARY’S NAME(受益人名称):
OKOKOK(ZUOSI) Information Consulting CO.,LTD
COMPANY ADDRESS:
Room 1008, Tower A2, Longrange World Office Building, No.18 Suzhou Street, Haidian District, Beijing China
REMARKS(附言):
SHANGHAI PUDONG DEVELOPMENT BANK, BEIJING BR.***SUB-BR
在线客服系统